Published in Hepatitis Weekly, December 16th, 1996
Isoniazid is an indispensable agent for the chemoprophylaxis and treatment of tuberculosis, but daily administration has been found to be hepatotoxic in between one and two percent of patients receiving the drug. This hepatotoxicity can be fatal if not recognized early.
The mechanism of isoniazid-induced hepatotoxicity is not currently known, and most previous research has focused on a rat model with the hypothesis that acetylhydrazine, a metabolite of isoniazid, is the cause of this toxicity.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.